Fibroblast Growth Factor (FGF, endocrine-relevant family)

Class Peptide growth factor hormoneReceptor FGFR1

Function

Fibroblast growth factors are a family of peptide signaling hormones involved in tissue growth, angiogenesis, metabolic regulation, wound healing, cellular differentiation, and endocrine communication. Different FGF family members perform specialized functions across developmental biology, connective tissue maintenance, skeletal physiology, and metabolic adaptation.

FGF signaling influences cell proliferation, extracellular matrix remodeling, endothelial communication, nutrient metabolism, and organ development. Endocrine-relevant FGFs such as FGF19, FGF21, and FGF23 function as circulating metabolic hormones that regulate bile acid metabolism, energy balance, phosphate homeostasis, and nutrient signaling pathways. Additional FGF family members contribute to tissue repair, angiogenesis, and developmental organization.

Production

FGFs are produced by numerous tissues including liver, adipose tissue, bone, endothelial cells, fibroblasts, skeletal muscle, epithelial tissues, and connective tissue structures. Most FGFs act locally through paracrine signaling, while certain endocrine FGFs circulate systemically and require co-receptor proteins for target-cell activation.

FGF synthesis reflects developmental signaling patterns, metabolic demand, tissue repair requirements, and endocrine communication pathways. Some family members are stored within extracellular matrix environments where controlled release regulates signaling availability.

Regulation

FGF production is regulated by nutrient availability, hypoxia, inflammatory cytokines, developmental pathways, endocrine signaling, mechanical stress, and tissue injury. Metabolic FGFs are particularly responsive to fasting, feeding, bile acid signaling, phosphate balance, and energy demand.

FGFs act through fibroblast growth factor receptors, a family of receptor tyrosine kinases that activate MAP kinase pathways, PI3K-AKT signaling, phospholipase cascades, and growth-regulatory transcription systems. Klotho co-receptors regulate signaling specificity for endocrine FGFs. Through these integrated growth and metabolic signaling systems, FGFs coordinate tissue adaptation, angiogenesis, metabolic communication, and developmental regulation.

Identity & Secretion

Primary Source GlandLiver (FGF21), ileum/enterocytes (FGF19), osteocytes (FGF23); many tissues express paracrine FGFs.

Secretion PatternContext-dependent; endocrine FGF21 rises with fasting/energy deficit cues; FGF19 postprandial bile acid signaling; FGF23 from bone with phosphate/Vit D context.

PrecursorPrepro-FGF → Pro-FGF → Mature FGF (family; endocrine members require co-receptors)

Nutrient Requirements

Nutrient Precursors

Dietary amino acids support peptide synthesis; endocrine action depends on Klotho family co-receptors.

Required Vitamins

Folate and B6 (cell division/amino acid metabolism contexts); Vitamin C (matrix environment)

Required Minerals

Magnesium and Zinc (kinase/signaling enzyme cofactors)

Key Foods

Leafy greens, legumes, whole grains, nuts, seeds, berries, citrus (support antioxidant status and normal metabolic signaling environments).

Targets & Signaling

Target Tissues

Liver, adipose tissue, skeletal muscle, bone, CNS, gastrointestinal tract, kidney (endocrine targets vary by member).

Feedback Loops

Homeostatic loops include nutrient/energy sensors, bile acid receptors (FXR/FGF19 axis), and phosphate–vitamin D regulation (FGF23 axis).

Second Messengers

RTK phosphorylation cascades; adaptor-mediated activation of MAPK and PI3K/Akt; intracellular Ca²⁺ via PLCγ.

Pathways Involved

RTK → RAS–RAF–MEK–ERK (MAPK); RTK → PI3K–Akt–mTOR; RTK → PLCγ–PKC; integration with nutrient/hormone sensors.

Key Functions

Coordinates energy adaptation (FGF21), bile acid synthesis feedback (FGF19), and phosphate/Vitamin D balance (FGF23); broader FGF family supports development and tissue maintenance.

Plant-Based Focus

Whole-food, fiber-rich plant patterns support redox balance and normal endocrine–metabolic signaling rhythms (context only).

Clinical Context

Assay Notes
Assays are member- and matrix-specific (e.g., FGF21, FGF19, FGF23 ELISA); preanalytics and binding proteins influence results.

Linked Knowledge

Phytochemicals

Quercetin, resveratrol, EGCG, catechins (studied in metabolic/RTK signaling contexts).

Amino Acids

Arginine (NO signaling context), glycine/proline (matrix protein context)

Foods

Legumes, oats, quinoa, leafy greens, berries, citrus, nuts, seeds, beetroot

Vitamins

Folate, B6, Vitamin C

Minerals

Magnesium, Zinc

Cancers (context)

Discussed widely in endocrine–metabolic adaptation literature (context only).

Ailments

Energy balance and nutrient-handling physiology (context only, non-medical).

Dietary Modulators

Fiber-rich, minimally processed plant foods support favorable metabolic signaling environments (context only).

Inhibitors / Activators

Inhibitors

Ultra-processed, high-refined-sugar/fat patterns may alter metabolic signaling environments (context only).

Activators

Physiologic cues such as fasting (FGF21 axis), postprandial bile acids (FGF19 axis), and phosphate/Vit D signals (FGF23 axis).

Summary

Endocrine-relevant FGFs coordinate systemic metabolic adaptation, bile acid feedback, and phosphate–vitamin D balance.

SUMMARY OF EFFECTS ON THE BODY

Supports energy homeostasis and adaptive tissue signaling under normal physiological conditions.

Research

PMID: 23395170; PMID: 31278036; PMID: 20558664